Anticoccidial Drugs Market Overview

Market Size & CAGR of Anticoccidial Drugs in 2021

The global anticoccidial drugs market is expected to have a growth rate of 3.61% CAGR from 2021 to 2030. As a result, the market is anticipated to grow by USD 1691.94 Million by 2028.

COVID-19 Impact on the Anticoccidial Drugs Market

The disease has spread to almost every country globally since the COVID-19 virus outbreak in December 2019, prompting the World Health Organization to declare it a public health emergency. Coccidiosis is a viral disease caused by a single-cell parasite that affects the intestinal tracts of animals. The pandemic has increased the demand for newer anticoccidial drugs to prevent and control coccidial infections in animals.

Anticoccidial Drugs Dynamics

Anticoccidial drugs are used to prevent and treat coccidiosis in animals. These drugs help in controlling the spread of the parasitic disease and are of two types: ionophores and chemical anticoccidials. The market is driven by factors such as increasing focus on animal health, rising meat consumption, and growing demand for quality veterinary healthcare products.

Segments and Related Analysis

- Drug Type: Antibiotic Anticoccidials, Ionophore Anticoccidials, Chemical Derivative Anticoccidials. The ionophore anticoccidials segment had the largest market share in 2022.
- Animal Type: Poultry, Swine, Fish, Cattle, Companion Animal. The poultry animal segment dominated the market in 2022.

By Region Analysis

- North America: The region had the most significant global market share in 2022, driven by advanced manufacturing techniques and the presence of a well-organized animal healthcare system.
- Europe: Expected to grow at a promising CAGR, fueled by the consumption rate of meat and the sophisticated pet care industry.
- Asia Pacific: Forecasted to grow at a CAGR of 4.3%, influenced by the growing pet population and demand for poultry products.

Key Market Players and Competitive Landscape

Noteworthy companies in the market include Bayer HealthCare, Zoetis, Elanco, Merial, Merck Animal Healthcare, Ceva Santé Animale, Virbac, Boehringer Ingelheim Animal Health, Novartis Animal Healthcare, and Smartvet Inc.

Recent Happenings in the Anticoccidial Drugs Market

- Amlan International introduced natural alternatives to anticoccidial drugs.
- Zoetis showcased significant weight gain in suckling calves from implants.
- Virbac launched Multimin for cattle.
- Ceva Sante Animale partnered with ProBioGen to transform poultry vaccines with proprietary technology.